KARBAZAN

KARBAZAN is a pharmaceutical tablet formulation containing Diethylcarbamazine Citrate IP 150 mg. It is classified as an antifilarial medicine and forms part of the pharmaceutical product range available through SupriMeda. The formulation is presented in a tablet dosage form, with a pack configuration of 10 × 10 tablets.

Diethylcarbamazine Citrate is an established active pharmaceutical ingredient included in pharmaceutical formulations for filarial infections. The 150 mg strength provides a clearly defined dosage specification for product identification, pharmaceutical cataloguing, and institutional procurement records. KARBAZAN can be listed within antifilarial medicines in a professional pharmaceutical product portfolio, helping hospitals, pharmacies, healthcare practitioners, and procurement teams identify the formulation by its brand name, composition, strength, and dosage form.